載入中
NASDAQFinancial ServicesShell Companies
最新資料
US$10.85
US$0.00 · 0.00%
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
前收盤價
US$10.85
US$0.00 · 0.00%
盤中時間採用ET。市場資料可能有所延遲。
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
日內區間
目前US$10.85
52週區間
目前US$10.85
盤中時間採用ET。市場資料可能有所延遲。
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
日內區間
目前US$10.85
52週區間
目前US$10.85
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 |
|---|---|---|
| 銷售、一般及管理費用 | 281.6萬 USD | 479.73 USD |
| 營業費用 | 281.6萬 USD | 479.73 USD |
| 利息收入 | 875.67萬 USD | — |
| 折舊和攤銷 | — | 47.97萬 USD |
| 營業利益 | −281.6萬 USD | −479 USD |
| 淨利 | 594.06萬 USD | −479 USD |
公司資料更新於 2026年10月11日。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。